NCT01679470View on ClinicalTrials.gov

Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Primary or Metastatic Lung Tumors
Interventions
DEVICE

AuroLase Therapy

Infusion of AuroShell particles followed by laser illumination for photothermal ablation of target lesions.

Trial Locations (1)

19124

Cancer Treatment Centers of America Eastern Regional Medical Center, Philadelphia

Sponsors
All Listed Sponsors
lead

Nanospectra Biosciences, Inc.

INDUSTRY

NCT01679470 - Efficacy Study of AuroLase Therapy in Subjects With Primary and/or Metastatic Lung Tumors | Biotech Hunter | Biotech Hunter